These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 31650967)

  • 1. Assessment of the compliance with minimum acceptable technical parameters proposed by PI-RADS v2 guidelines in multiparametric prostate MRI acquisition in tertiary referral hospitals in the Republic of Turkey.
    Coşkun M; Sarp AF; Karasu Ş; Gelal MF; Türkbey B
    Diagn Interv Radiol; 2019 Nov; 25(6):421-427. PubMed ID: 31650967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Facilities' Adherence to PI-RADS v2 Minimum Technical Standards for the Performance of Prostate MRI.
    Esses SJ; Taneja SS; Rosenkrantz AB
    Acad Radiol; 2018 Feb; 25(2):188-195. PubMed ID: 29107458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing Prostate Imaging Practices in Saudi Arabian Hospitals: A Comprehensive Analysis of PI-RADS Compliance in Multiparametric MRI.
    Alshuhri MS; Alhulail AA; Alqahtani AGM; Madkhali YA; Alshehri AM; Alghuraybi RA; Alqahtani S; BinMhusien MA; Alqahtani M; Qaisi A
    Curr Med Imaging; 2024; 20():e15734056318591. PubMed ID: 39041255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional Standardization of Prostate Multiparametric MRI Performance and Reporting: Is There a Role for a Director of Prostate Imaging?
    Abreu-Gomez J; Shabana W; McInnes MDF; O'Sullivan JP; Morash C; Schieda N
    AJR Am J Roentgenol; 2019 Oct; 213(4):844-850. PubMed ID: 31180739
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
    Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
    J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
    Tamada T; Kido A; Takeuchi M; Yamamoto A; Miyaji Y; Kanomata N; Sone T
    Eur J Radiol; 2019 Dec; 121():108704. PubMed ID: 31669798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?
    Hoffmann R; Logan C; O'Callaghan M; Gormly K; Chan K; Foreman D
    Int Urol Nephrol; 2018 Jan; 50(1):13-19. PubMed ID: 29188489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
    Girometti R; Giannarini G; Greco F; Isola M; Cereser L; Como G; Sioletic S; Pizzolitto S; Crestani A; Ficarra V; Zuiani C
    J Magn Reson Imaging; 2019 Feb; 49(2):546-555. PubMed ID: 30187600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiparametric MRI of the prostate].
    Herrmann J; Kaufmann S; Zhang C; Rausch S; Bedke J; Stenzl A; Nikolaou K; Kruck S; Seith F
    Urologe A; 2022 Apr; 61(4):428-440. PubMed ID: 35389061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate MRI evolution in clinical practice: Audit of tumour detection and staging versus prostatectomy with staged introduction of multiparametric MRI and Prostate Imaging Reporting and Data System v2 reporting.
    Raeside M; Low A; Cohen P; Sutherland P; Gormly K
    J Med Imaging Radiat Oncol; 2019 Aug; 63(4):487-494. PubMed ID: 30951248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.
    Feng ZY; Wang L; Min XD; Wang SG; Wang GP; Cai J
    Chin Med J (Engl); 2016 Oct; 129(20):2451-2459. PubMed ID: 27748338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
    Yim JH; Kim CK; Kim JH
    J Magn Reson Imaging; 2018 Apr; 47(4):1072-1079. PubMed ID: 28901655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
    Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation.
    Israël B; Leest MV; Sedelaar M; Padhani AR; Zámecnik P; Barentsz JO
    Eur Urol; 2020 Apr; 77(4):469-480. PubMed ID: 31767492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate MRI technical parameters standardization: A systematic review on adherence to PI-RADSv2 acquisition protocol.
    Cuocolo R; Stanzione A; Ponsiglione A; Verde F; Ventimiglia A; Romeo V; Petretta M; Imbriaco M
    Eur J Radiol; 2019 Nov; 120():108662. PubMed ID: 31539790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Spatial Correlation Between Multiparametric MRI Performance and Prostate Cancer.
    Zabihollahy F; Naim S; Wibulpolprasert P; Reiter RE; Raman SS; Sung K
    J Magn Reson Imaging; 2024 Nov; 60(5):2184-2195. PubMed ID: 38345143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review.
    Hassanzadeh E; Glazer DI; Dunne RM; Fennessy FM; Harisinghani MG; Tempany CM
    Abdom Radiol (NY); 2017 Jan; 42(1):278-289. PubMed ID: 27522352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
    Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
    Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer.
    Van Nieuwenhove S; Saussez TP; Thiry S; Trefois P; Annet L; Michoux N; Lecouvet F; Tombal B
    BJU Int; 2019 Mar; 123(3):411-420. PubMed ID: 30240059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.